Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Long

Showing results (311-320 of 320) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 320 results.
Journal of the American College of Cardiology|September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR ProjectCharles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.
Seminars in Thrombosis and Hemostasis|November 1, 2012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)Sony Jacob, Brianne L Dunn, Zaina P Qureshi, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Scientific Reports|July 28, 2025
Author Correction: Longitudinal fecal microbiota and volatile metabolomics preceding necrotizing enterocolitis in preterm infants: a case-control studyS El Manouni El Hassani, N M Frerichs, D J C Berkhout, et al.
Scientific Reports|March 27, 2025
Longitudinal fecal microbiota and volatile metabolomics preceding necrotizing enterocolitis in preterm infants: a case-control studyS El Manouni El Hassani, N M Frerichs, D J C Berkhout, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Eclinicalmedicine|April 16, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Michael Bubenheim, Ygal Benhamou, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|September 30, 2024
[Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)]M Hu, C Yang, H H Liu, et al.
Pageof 32

Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Journal of the American College of Cardiology|September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR ProjectCharles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.
Seminars in Thrombosis and Hemostasis|November 1, 2012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)Sony Jacob, Brianne L Dunn, Zaina P Qureshi, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Scientific Reports|July 28, 2025
Author Correction: Longitudinal fecal microbiota and volatile metabolomics preceding necrotizing enterocolitis in preterm infants: a case-control studyS El Manouni El Hassani, N M Frerichs, D J C Berkhout, et al.
Scientific Reports|March 27, 2025
Longitudinal fecal microbiota and volatile metabolomics preceding necrotizing enterocolitis in preterm infants: a case-control studyS El Manouni El Hassani, N M Frerichs, D J C Berkhout, et al.
Blood Advances|December 15, 2023
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP RegistryMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Eclinicalmedicine|April 16, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Michael Bubenheim, Ygal Benhamou, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|September 30, 2024
[Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)]M Hu, C Yang, H H Liu, et al.
Pageof 32